Huntington’s disease (HD) is an autosomal-dominantly inherited, fatal, neurodegenerative disorder. Patients present with motor dysfunction, psychiatric disturbances, cognitive impairments and metabolic abnormalities. The sole cause of developing HD is the expansion of an unstable repeat of CAG base triplets in the coding region of the Huntingtin gene, HTT. CAG repeat lengths of up to 34 are considered to be physiological, while more than 35 CAG repeats lead most likely to the development of HD. The age of disease onset correlates inversely with CAG repeat length and starts at the age of 40–50 years.
BACHD rats overexpress full-length human mutant HTT (mHTT) with 97 alternating CAA/CAG repeats on a bacterial artificial chromosome (BAC).
Hemizygous BACHD rats show:
- mHTT aggregates
- Motor deficits
- Reversal learning deficits
- Reduced anxiety
- Striatal alterations
Figure 1: Rota Rod and Morris water maze. A: Rota Rod test was performed from month 1 to 5. Latency to fall off the rod in seconds. B: 7 months old BACHD rats present a significantly longer latency to find the platform in the reversal trials on day 9 of testing, animals present no learning deficits during the first 8 days of training (data not shown). Two-way ANOVA with Bonferroni post hoc test. Mean ± SEM. n = 15 per group. **p<0.01 ***p<0.001.
QPS Neuropharmacology is ready to provide samples (brain tissue, CSF etc.) from these animals for analyses in your laboratory.
We would be happy to test your compounds in our BACHD transgenic rat model! The most common readouts are:
- Motor deficits
- Learning and Reversal learning deficits
- polyQ HTT quantification
Looking for something else? Please contact us!